Two types of DNA aptamers were used: one was a CD44 aptamer for targeting CD44+ breast CSCs, and the other was an aptamer for targeting transmembrane glycoprotein mucin 1 (MUC1) expressed on breast cancer cells. The gene discussed is CD44; the disease is breast carcinoma.